Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 23.00
+0.90 (4.07%)
At close: Jan 30, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 132.65 million as of January 30, 2026. Its market cap has decreased by -12.15% in one year.
Market Cap
132.65M
Enterprise Value
280.16M
Revenue
839.38K
Ranking
n/a
PE Ratio
5.06
Stock Price
23.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 132.65M, a decrease of -44.83%. That is a compound annual growth rate of -13.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 127.46M | -10.53% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 906.41M |
| Basilea Pharmaceutica AG | 674.62M |
| Newron Pharmaceuticals | 394.29M |
| Santhera Pharmaceuticals Holding AG | 177.93M |
| BioVersys AG | 140.94M |
| Molecular Partners AG | 120.61M |
| EvoNext Holdings | 5.91M |
| Addex Therapeutics | 5.83M |